产品编号 | 图片 | CAS No. | 名称及描述 | 规格 | 价格 | 分子式 | 快速订购 |
---|---|---|---|---|---|---|---|
GC31366-100mg |
|
1291094-73-9 |
Licogliflozin (LIK066) - Glpbio |
0 | 需询价 | C23H28O7 | |
GC31366-50mg |
|
1291094-73-9 |
Licogliflozin (LIK066) - Glpbio |
0 | 需询价 | C23H28O7 | |
GC31366-25mg |
|
1291094-73-9 |
Licogliflozin (LIK066) - Glpbio |
0 | 需询价 | C23H28O7 | |
GC31366-10mg |
|
1291094-73-9 |
Licogliflozin (LIK066) - Glpbio |
0 | 需询价 | C23H28O7 | |
GC31366-5mg |
|
1291094-73-9 |
Licogliflozin (LIK066) - Glpbio |
0 | 需询价 | C23H28O7 | |
GC31366-1mg |
|
1291094-73-9 |
Licogliflozin (LIK066) - Glpbio |
0 | 需询价 | C23H28O7 | |
GC31366-10mM(1mLinDMSO) |
|
1291094-73-9 |
Licogliflozin (LIK066) - Glpbio |
0 | 需询价 | C23H28O7 | |
GC31365-1g |
|
11042-64-1 |
γ-Oryzanol - Glpbio |
0 | 需询价 | C40H58O4 | |
GC31365-10mM(1mLinDMSO) |
|
11042-64-1 |
γ-Oryzanol - Glpbio |
0 | 需询价 | C40H58O4 | |
GC31364-100mg |
|
3351-86-8 |
Fucoxanthin (all-trans-Fucoxanthin) - Glpbio |
0 | 需询价 | C42H58O6 | |
GC31364-50mg |
|
3351-86-8 |
Fucoxanthin (all-trans-Fucoxanthin) - Glpbio |
0 | 需询价 | C42H58O6 | |
GC31364-25mg |
|
3351-86-8 |
Fucoxanthin (all-trans-Fucoxanthin) - Glpbio |
0 | 需询价 | C42H58O6 | |
GC31364-10mg |
|
3351-86-8 |
Fucoxanthin (all-trans-Fucoxanthin) - Glpbio |
0 | 需询价 | C42H58O6 | |
GC31364-5mg |
|
3351-86-8 |
Fucoxanthin (all-trans-Fucoxanthin) - Glpbio |
0 | 需询价 | C42H58O6 | |
GC31364-10mM(1mLinDMSO) |
|
3351-86-8 |
Fucoxanthin (all-trans-Fucoxanthin) - Glpbio |
0 | 需询价 | C42H58O6 | |
GC31363-100mg |
|
2212020-52-3 |
GLP-1 receptor agonist 1 - Glpbio |
0 | 需询价 | C48H48F2N10O5 | |
GC31363-50mg |
|
2212020-52-3 |
GLP-1 receptor agonist 1 - Glpbio |
0 | 需询价 | C48H48F2N10O5 | |
GC31363-25mg |
|
2212020-52-3 |
GLP-1 receptor agonist 1 - Glpbio |
0 | 需询价 | C48H48F2N10O5 | |
GC31363-10mg |
|
2212020-52-3 |
GLP-1 receptor agonist 1 - Glpbio |
0 | 需询价 | C48H48F2N10O5 | |
GC31363-5mg |
|
2212020-52-3 |
GLP-1 receptor agonist 1 - Glpbio |
0 | 需询价 | C48H48F2N10O5 | |